Nei Podcast

In this episode, Dr. Leslie Citrome addresses your unanswered questions from his presentation, There’s No Place Like Home: Addressing Agitation in Dementia.

What is the role of the 5HT2A receptor in the therapeutic actions of psychedelics? What additional mechanisms may be involved in the therapeutic benefits of classic psychedelics? Is the psychedelic trip necessary for the therapeutic benefit of psychedelics?  Brought to you by the NEI Podcast, the PsychopharmaStahlogy Show tackles the most novel, exciting, and controversial topics in psychopharmacology in a series of themes. This theme is on the role of psychedelics in modern psychiatry.  Today, Dr. Andy Cutler interviews Dr. Roger McIntyre and Dr. Stephen Stahl about the current understanding of the neurobiological mechanisms underlying the therapeutic benefits of psychedelics.  Let’s listen to Part 2 of our theme: Classic Psychedelics for the Modern Psychopharmacologist.  Subscribe to the NEI Podcast, so that you don’t miss another episode!   

In this episode, Dr. Laxman Bahroo addresses your unanswered questions from his presentation, Neurology for Psychiatrists.

In this episode, Dr. Roger McIntyre addresses your unanswered questions from his presentation, Unveiling the Therapeutic Potential: Evidence Supporting the Use of Psychedelics for PTSD, SUD, and Other Indications, at the Pre-Conference Psychedelics Workshop.

In this episode, Dr. Timothy Wilens addresses your unanswered questions from his presentation, Double Trouble: Diagnosis and Pharmacotherapy of ADHD and Juvenile Bipolar Disorder, at the Child & Adolescent Psychiatry Academy.

In this episode, Dr. Robyn Thom addresses your unanswered questions from her presentation, The Full Picture: Managing Autism Spectrum Disorder and Its Frequent Psychiatric Comorbidities, at the Child & Adolescent Psychiatry Academy.

In this episode, Dr. Jeffrey Strawn addresses your unanswered questions from his presentation, Along for the Ride: Treatment Considerations for Childhood Psychiatric Disorders With Co-Occurring Anxiety, at the Child & Adolescent Psychiatry Academy.

Stigma surrounding mental illness and its treatment can be pervasive and negatively impact the quality of life of patients suffering with mental health problems. What role do psychiatric healthcare providers play in addressing and combating mental illness stigma? How do cultural factors influence the perception of mental illness and stigma? What are the best strategies for reducing stigma related to mental illness? Dawn I. Velligan, PhD is a Professor in the Department of Psychiatry, Chief of the Division of Community Recovery, Research and Training, and the Henry B. Dielmann Chair at the University of Texas Health Science Center in San Antonio, Texas. Dr. Velligan’s internationally recognized research program focuses on the development and testing of psychosocial treatments to improve medication interest, follow-through, and outcomes for people with schizophrenia. She developed cognitive adaptation training; a treatment designed to improve functional outcomes for people with serious mental illness. Dr. Vel

The 19th annual NEI Congress is upon us. Whether you’ve already secured your spot to join us in person at The Broadmoor in Colorado Springs or plan to attend virtually via simulcast OR are still unsure if this event is for you, you’re in luck. This is our Congress preview episode. Congress chairman, Dr. Andrew Cutler interviews a few of the brilliant faculty members who will be speaking at this year’s conference for a sneak peek of their presentations and finds out what they are looking forward to at the upcoming event.

What are classic psychedelic drugs and how has their role in psychiatry changed over time? What are the potential benefits of using psychedelic therapy for treating psychiatric disorders? Are there any significant risks and what are the potential side effects associated with psychedelic therapy? Brought to you by the NEI Podcast, the PsychopharmaStahlogy Show tackles the most novel, exciting, and controversial topics in psychopharmacology in a series of themes. This theme is on the role of psychedelics in modern psychiatry. Today, Dr. Andy Cutler interviews Dr. Stephen Stahl on the current state of psychedelic research in psychiatry.  Let’s listen to Part 1 of our theme: Classic Psychedelics for the Modern Psychopharmacologist. Subscribe to the NEI Podcast, so that you don’t miss another episode!

How large of an issue is treatment non-adherence in the serious mental illness (SMI) population? How does therapeutic alliance influence treatment adherence? What are some effective strategies for improving medication adherence? Dr. Andrew Cutler interviews Dr. Peter Weiden to find answers to these questions and more! Peter J. Weiden, MD is an internationally recognized expert in the treatment of schizophrenia and related psychotic disorders. Dr. Weiden has a distinguished career spanning academia, clinical trials, and industry. His academic career included positions as Professor of Psychiatry at SUNY Downstate Medical Center from 1999-2007 and at UIC Medical Center from 2007-2014. Dr. Weiden served as Chief Medical Officer for Uptown Research in Chicago and continued as clinical investigator of new and emerging treatments for schizophrenia. His industry experience includes joining Alkermes to focus on development of new treatments for schizophrenia, including the long-acting formulation aripiprazole laurox

In this re-release episode, Dr. Andrew Cutler interviews Dr. Katherine Warburton about the history of criminalization of serious mental illness, the efforts to decriminalize mental illness, and the development and success of diversion programs. Dr. Katherine Warburton is Medical Director/Deputy Director of Clinical Operations for the California Department of State Hospitals. Prior to that, she was the Chief of Forensic Psychiatry at Napa State Hospital. She is on the volunteer clinical faculty of the UC Davis Division of Psychiatry and the Law. Link to “Decriminalizing Mental Illness” by Drs. Warburton and Stahl: https://www.amazon.com/Decriminalizing-Mental-Illness-Katherine-Warburton/dp/1108826954/ref=sr_1_1?crid=18XJ6RE7Y5X5M&keywords=warburton+stahl&qid=1657746214&sprefix=warburton+stahl%2Caps%2C112&sr=8-1

During National Recovery Month, we are re-releasing this classic episode in which Dr. Sabrina Segal interviews addiction expert Dr. Nzinga  Harrison about the need to address stigma and misconceptions surrounding the topic of addiction. When it comes to addiction, there are many questions. What does it mean to say that someone is in recovery? What are some behavioral addictions that most people don’t think about? Are there such things as healthy addictions? In this episode, Dr. Harrison shares a refreshing and novel perspective on the topics of addiction and recovery. A well-respected physician and educator, Dr. Harrison is the host of the In Recovery weekly podcast by Lemonada Media, in which she engages a large audience on all things addiction with the goal of leading with compassion, evidence and reducing stigma. She is Chief Medical Officer and Co-Founder of  Eleanor Health, an innovative company that provides comprehensive, longitudinal outpatient care for individuals experiencing opioid and other subs

In this re-release episode, Dr. Andrew Cutler interviews Dr. Stephen Stahl about the dark side of neuroplasticity, or pathologic neuroplasticity, and what we may be able to do to combat it.

What led you to pursue a career in auditory neuroscience and what is the mission behind your laboratory, Brainvolts? What is the effect of bilingualism on Alzheimer’s disease? How can sound be used for the assessment of traumatic brain injury and other neurological conditions? In this episode, Dr. Nina Kraus addresses these questions and much more about the clinical applications for auditory neuroscience research. Her laboratory at Northwestern University, Brainvolts, has discovered how to measure the biology of auditory processing with unprecedented precision. The implications of the research conducted there extends beyond the laboratory to schools, community centers, and clinics. Nina Kraus, Ph.D. is a professor at Northwestern University who studies the biology of auditory learning. Through a series of innovative studies involving thousands of research participants from birth to age 90, her research has found that our lives in sound, for better (musicians, bilinguals) or worse (language disorders, concuss

In this CME episode, Dr. Andrew Cutler interviews Dr. Stephen Stahl and Dr. Sarah Vinson about the ethicality and morality of involuntary treatment for serious mental illness (SMI), the relationship between SMI and the criminal justice system, and community-based changes that are being pursued to improve treatment and reduce the criminalization of SMI. Optional CME/CE Credits and Certificate Instructions: After listening to the podcast, to take the optional posttest and receive CME/CE credit, click: https://nei.global/POD23-SMI Learning Objectives: After completing this educational activity, you should be better able to: Recognize the neuroethics involved in involuntary treatment of serious mental illness Identify methods to prevent patients with serious mental illness from entering the criminal justice system, including the utility of diversion programs Institute community-based changes that have the potential to reduce the criminalization of serious mental illness, both on the individual and the policy le

In this re-release episode, Dr. Andrew Cutler interviews Drs. Marko Perko and Stephen Stahl about their book, Tesla: His Tremendous and Troubled Life, which explores the intersection between Tesla’s genius, his creativity, and his bipolar disorder. Sadly, Dr. Marko Perko passed away last fall after a battle with cancer. He was a prolific writer and a great mind, and we re-release this episode in his honor.   Learn more about Tesla: His Tremendous and Trouble Life

NEI Podcast is taking a temporary hiatus over the summer. From July through September, we will revisit some of our most compelling episodes, on topics that remain as relevant today as when they first aired. New episodes will resume in the fall; make sure you are subscribed so that you don’t miss out!  ***************************** What is unique about collaborative care when it comes to mental health? Can you share some of the step-by-step guide to implementing the core model in clinical practice for collaborative care? In this episode, Dr. Anna Ratzliff answers these questions and much more!   Dr. Anna Ratzliff is a national expert on collaborative care, and specifically on training teams to implement and deliver mental health treatment in primary care settings. Her passion for translating complex research ideas into practical real-world applications began when she received her MD and PhD in Anatomy and Neurobiology as part of the Medical Scientist Training Program at the University of California at Irvine.

What are some of the greatest challenges when treating ADHD in the elderly population? Are stimulants safe in the elderly population? How do hormonal changes influence ADD or ADHD in women throughout life?  With this special series, brought to you by the NEI Podcast, we will address a different theme in psychopharmacology every 3 months. Each theme is split into 3 parts, with one part released each month. This theme is on novel perspectives and novel treatment approaches for Attention Deficit Hyperactivity Disorder (ADHD). Today, Dr. Andy Cutler interviews Dr. David Goodman on treating ADHD across the lifespan. Let’s listen in to Part 3 of our theme: Treating ADHD Across the Lifespan. Subscribe to the NEI Podcast, so that you don’t miss another episode!

What is avoidant/restrictive food intake disorder or ARFID? How does it differ from other disorders? How are intestinal microbiota involved when it comes to eating disorders? Dr. Cynthia Bulik is a Distinguished Professor of Eating Disorders and Founding Director of the University of North Carolina (UNC) Center of Excellence for Eating Disorders and Professor of Nutrition, Gillings School of Global Public Health; and Associate Director, UNC Center for Psychiatric Genomics. Dr. Bulik’s research teams at UNC (Center of Excellence for Eating Disorders-CEED) and Karolinska Institute (Centre for Eating Disorders Innovation-CEDI) are dedicated to deepening our understanding of the underlying biology and genetics of eating disorders and to advancing the evidence base for the treatment of these illnesses. As founder and co-chair of the Eating Disorders Working Group of the Psychiatric Genomics Consortium (PGC-ED), she leads the global effort to identify actionable genomic variation in eating disorders. She is Princip